Showing results (271-280 of 477) with videos related to
Sort By:
Pageof 48
JACC. Cardiovascular Interventions|April 25, 2020
The Natural History of Nonculprit Lesions in STEMI: An FFR Substudy of the Compare-Acute TrialZsolt Piróth, Bianca M Boxma-de Klerk, Elmir Omerovic, et al.Circulation|September 1, 2005
Randomized evaluation of the effects of filter-based distal protection on myocardial perfusion and infarct size after primary percutaneous catheter intervention in myocardial infarction with and without ST-segment elevationMichael Gick, Nikolaus Jander, Hans-Peter Bestehorn, et al.Journal of the American College of Cardiology|December 8, 2004
Influence of treatment duration with a 600-mg dose of clopidogrel before percutaneous coronary revascularizationDavid E Kandzari, Peter B Berger, Adnan Kastrati, et al.European Heart Journal|March 1, 2005
One year outcomes with abciximab vs. placebo during percutaneous coronary intervention after pre-treatment with clopidogrelAlbert Schömig, Claus Schmitt, Alban Dibra, et al.Journal of the American College of Cardiology|May 17, 2008
Cytochrome P450 2C19 681G>A polymorphism and high on-clopidogrel platelet reactivity associated with adverse 1-year clinical outcome of elective percutaneous coronary intervention with drug-eluting or bare-metal stentsDietmar Trenk, Willibald Hochholzer, Martin F Fromm, et al.Clinical Research in Cardiology : Official Journal of the German Cardiac Society|April 28, 2022
Rotational atherectomy of calcified coronary lesions: current practice and insights from two randomized trialsAbdelhakim Allali, Mohamed Abdel-Wahab, Karim Elbasha, et al.Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|February 27, 2019
Safety and performance of the second-generation drug-eluting absorbable metal scaffold (DREAMS 2G) in patients with de novo coronary lesions: three-year clinical results and angiographic findings of the BIOSOLVE-II first-in-man trialMichael Haude, Hüseyin Ince, Ralph Toelg, et al.The New England Journal of Medicine|January 16, 2004
A clinical trial of abciximab in elective percutaneous coronary intervention after pretreatment with clopidogrelAdnan Kastrati, Julinda Mehilli, Helmut Schühlen, et al.Clinica Chimica Acta; International Journal of Clinical Chemistry|September 16, 2021
Prognostic value of glomerular function estimated by Cockcroft-Gault creatinine clearance, MDRD-4, CKD-EPI and European Kidney Function Consortium equations in patients with acute coronary syndromesGjin Ndrepepa, Stefan Holdenrieder, Franz-Josef Neumann, et al.Journal of Clinical Medicine|February 26, 2025
Influence of Prosthesis Position on Pacing Burden and Long-Term Survival in TAVI Patients with New PacemakerRamona Schmitt, Yannick Salz-Sculean, Klaus Kaier, et al.Pageof 48